- Home
- POWW vs CMPX Comparison
POWW vs CMPX Comparison
Compare POWW & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POWW
- CMPX
- Stock Information
- Founded
- POWW 1990
- CMPX 2014
- Country
- POWW United States
- CMPX United States
- Employees
- POWW N/A
- CMPX N/A
- Industry
- POWW Ordnance And Accessories
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- POWW Industrials
- CMPX Health Care
- Exchange
- POWW Nasdaq
- CMPX Nasdaq
- Market Cap
- POWW 219.7M
- CMPX 229.5M
- IPO Year
- POWW N/A
- CMPX N/A
- Fundamental
- Price
- POWW $1.99
- CMPX $1.82
- Analyst Decision
- POWW Hold
- CMPX Strong Buy
- Analyst Count
- POWW 1
- CMPX 8
- Target Price
- POWW $1.50
- CMPX $13.13
- AVG Volume (30 Days)
- POWW 584.8K
- CMPX 762.7K
- Earning Date
- POWW 06-12-2025
- CMPX 05-08-2025
- Dividend Yield
- POWW N/A
- CMPX N/A
- EPS Growth
- POWW N/A
- CMPX N/A
- EPS
- POWW N/A
- CMPX N/A
- Revenue
- POWW $135,498,023.00
- CMPX $850,000.00
- Revenue This Year
- POWW $5.67
- CMPX $47.65
- Revenue Next Year
- POWW N/A
- CMPX $2,622.79
- P/E Ratio
- POWW N/A
- CMPX N/A
- Revenue Growth
- POWW N/A
- CMPX N/A
- 52 Week Low
- POWW $0.95
- CMPX $0.77
- 52 Week High
- POWW $2.86
- CMPX $4.08
- Technical
- Relative Strength Index (RSI)
- POWW 67.78
- CMPX 46.49
- Support Level
- POWW $1.93
- CMPX $1.79
- Resistance Level
- POWW $2.05
- CMPX $1.95
- Average True Range (ATR)
- POWW 0.12
- CMPX 0.14
- MACD
- POWW 0.02
- CMPX 0.01
- Stochastic Oscillator
- POWW 75.86
- CMPX 29.52
About POWW AMMO Inc.
AMMO Inc is the owner of GunBroker.com, the online marketplace serving the firearms and shooting sports industries, and a vertically integrated producer of high-performance ammunition and components. It engages in the design, manufacture, and market of ammunition products in the Shooting sports industry in the United States. The firm's product segment comprises Ammunition and Marketplace. The Ammunition segment engages in the design, production, and marketing of ammunition and ammunition component products and the marketplace segment consists of the GunBroker.com marketplace. The company generates the majority of its revenue from the Ammunition segment.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.